Ichor Biologics


Ichor Biologics is a NYC-based, pre-clinical biotechnology company dedicated to accelerating cures for infectious diseases through the development of antibody-based therapeutics. They leverage a novel high-throughput platform for the isolation and characterization of naturally occurring human antibodies, aiming to produce safe and effective therapeutics and establish strategic industry partnerships.

Industries

biotechnology
health-care
therapeutics

Nr. of Employees

small (1-50)

Ichor Biologics

New York, New York, United States, North America


Services

Antibody discovery and preclinical development services

End-to-end discovery and preclinical optimization of human monoclonal antibodies against infectious pathogens, including candidate isolation, characterization and in vivo efficacy testing.

Immune-profiling and assay development

Design and deployment of assays to detect pathogen-specific immune responses, including long-term post-infection detection methods to identify protective immune signatures.

Machine learning–driven antibody design support

Application of machine learning tools to identify antibody binding sites and propose optimized antibody variants for improved pathogen targeting.

Expertise Areas

  • Antibody discovery and engineering
  • Infectious disease therapeutics
  • Preclinical development and in vivo efficacy testing
  • Immune-profiling assay development
  • Show More (3)

Key Technologies

  • High-throughput antibody screening
  • Monoclonal antibody isolation and characterization
  • Antigen production and presentation techniques
  • Serological and pathogen-specific immunoassays
  • Show More (3)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.